Comparing Ocrelizumab to Interferon/Glatiramer Acetate in People with Multiple Sclerosis over Age 60

AuthID
P-00Z-KAP
22
Author(s)
Foong, YC
·
Zhu, C
·
Merlo, D
·
Gresle, M
·
Buzzard, K
·
Zhong, M
·
Yeh, W
·
Skibina, O
·
[+1]·
[+1]·
Lechner Scott, J
·
Butzkueven, H
·
van der Walt, A
1
Group Author(s)
MSBASE Study Grp
Document Type
Abstract
Year published
2023
Published
in MULTIPLE SCLEROSIS JOURNAL, ISSN: 1352-4585
Volume: 29, Pages: 32-33 (2)
Conference
9Th Joint Ectrims-Actrims Meeting, Date: OCT 11-13, 2023, Location: Milan, ITALY
Indexing
Publication Identifiers
Wos: WOS:001091311300045
Source Identifiers
ISSN: 1352-4585
Export Publication Metadata
Marked List
Info
At this moment we don't have any links to full text documens.
Name Order Name   Name Order Name   Name Order Name
1 Foong, YC;   2 Zhu, C;   3 Merlo, D;
4 Gresle, M;   5 Buzzard, K;   6 Zhong, M;
7 Yeh, W;   8 Jokubaitis, V;   9 Skibina, O;
10 Ozakbas, S;   11 Patti, F;   12 Grammond, P;
13 Amato, MP;   14 Kalincik, T;   15 Horakova, D;
16 Havrdova, E;   17 Weinstock Guttman, B;   18 Lechner Scott, J;
19 Boz, C;   20 Sá, MJ;   21 Butzkueven, H;
22 van der Walt, A;